Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#191 / 200 Total
AZTR - Azitra Inc - Stock Price Chart
TickerAZTR [AMEX]
CompanyAzitra Inc
CountryUSA
IndustryBiotechnology
Market Cap0.99MEPS (ttm)-27.84
P/E-EPS this Y97.91%
Forward P/E-EPS next Y66.96%
PEG-EPS past 5Y-
P/S1.73EPS next 5Y-
P/B0.23EPS Q/Q44.58%
Dividend-Sales Q/Q-100.00%
Insider Own44.22%Inst Own5.20%
Insider Trans-Inst Trans-
Short Float11.36%EarningsMay 09/a
Analyst Recom1.00Target Price3.00
Avg Volume1.64M52W Range1.08 - 119.10
Jul-25-24 05:57PM CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering (Business Wire) -9.65%
Jul-23-24 09:20PM Azitra, Inc. Announces Pricing of $10.0 Million Public Offering (Business Wire) +206.79% -76.46%
08:00AM Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents (Business Wire)
Jun-27-24 04:05PM Azitra, Inc. Announces Reverse Stock Split (Business Wire) +12.72% -30.15%
May-31-24 08:00AM Azitra, Inc. Announces Presentation at the 2024 BIO International Convention (Business Wire)
May-17-24 08:00AM Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting (Business Wire) -8.22%
May-10-24 08:00AM Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting (Business Wire) -13.08%
May-09-24 05:00PM Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates (Business Wire)
Apr-22-24 04:30PM Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting (Business Wire) +18.77%
Apr-18-24 04:15PM Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024 (Business Wire) -5.10%
SNES - SenesTech Inc - Stock Price Chart
TickerSNES [NASD]
CompanySenesTech Inc
CountryUSA
IndustrySpecialty Chemicals
Market Cap2.35MEPS (ttm)-146.47
P/E-EPS this Y90.44%
Forward P/E-EPS next Y59.09%
PEG-EPS past 5Y67.19%
P/S1.70EPS next 5Y30.00%
P/B0.51EPS Q/Q97.76%
Dividend-Sales Q/Q78.11%
Insider Own0.03%Inst Own3.41%
Insider Trans0.00%Inst Trans0.20%
Short Float0.88%EarningsMay 09/a
Analyst Recom1.00Target Price35.00
Avg Volume12.17K52W Range4.00 - 115.20
Jul-23-24 11:30AM SenesTech Announces Reverse Stock Split (PR Newswire) -24.25%
Jun-26-24 09:00AM SenesTech's Evolve Fertility Control Solution for Rats To Be Deployed in the U.S. Virgin Islands (PR Newswire)
Jun-12-24 07:00AM Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now (GlobeNewswire)
Jun-11-24 07:00AM Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now (GlobeNewswire)
May-30-24 12:10PM SenesTech (SNES) to Gain Market With Evolve's Launch on Amazon (Zacks)
May-23-24 09:00AM SenesTech to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 (PR Newswire) -7.56%
May-22-24 09:00AM SenesTech Launches Evolve Fertility Control Solution for Rats on Amazon, the World's Largest Online Retailer (PR Newswire) +8.09%
May-20-24 09:46AM Should You Add SenesTech (SNES) to Your Portfolio? (Insider Monkey)
May-12-24 09:32AM SenesTech, Inc. (NASDAQ:SNES) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 04:05PM SenesTech Announces First Quarter 2024 Financial Results (PR Newswire) +9.06% -26.19%
GNTA - Genenta Science SpA ADR - Stock Price Chart
TickerGNTA [NASD]
CompanyGenenta Science SpA ADR
CountryItaly
IndustryBiotechnology
Market Cap76.34MEPS (ttm)-0.69
P/E-EPS this Y-65.02%
Forward P/E-EPS next Y-17.86%
PEG-EPS past 5Y-24.90%
P/S-EPS next 5Y-
P/B3.38EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own5.35%
Insider Trans-Inst Trans-
Short Float-EarningsFeb 28
Analyst Recom1.00Target Price25.21
Avg Volume14.35K52W Range2.20 - 6.19
May-28-24 06:10AM 7 Penny Biotech Stocks to Triple Your Investment (InvestorPlace)
May-06-24 06:25AM Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider (GlobeNewswire)
Feb-08-24 05:00AM Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors (GlobeNewswire)
Sep-06-23 07:00AM Genenta to Present at Upcoming Scientific and Investor Conferences (GlobeNewswire)
Jul-28-23 03:00AM Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments (GlobeNewswire) -6.29%
Jul-08-23 09:57AM Here's Why We're Not Too Worried About Genenta Science's (NASDAQ:GNTA) Cash Burn Situation (Simply Wall St.)
Jun-29-23 07:00AM The European Commission Grants Orphan Drug Designation to Temferon for Treatment of Glioma (GlobeNewswire)
May-17-23 06:34AM Insiders own 30% of Genenta Science S.p.A. (NASDAQ:GNTA) shares but individual investors control 59% of the company (Simply Wall St.)
May-16-23 07:00AM Genenta to Provide Update on Lead Product Temferon (GlobeNewswire) +9.80%
May-09-23 07:15AM Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
ADCT - Adc Therapeutics SA - Stock Price Chart
TickerADCT [NYSE, RUT]
CompanyAdc Therapeutics SA
CountrySwitzerland
IndustryBiotechnology
Market Cap349.31MEPS (ttm)-2.76
P/E-EPS this Y35.76%
Forward P/E-EPS next Y16.57%
PEG-EPS past 5Y84.52%
P/S5.09EPS next 5Y15.80%
P/B-EPS Q/Q23.23%
Dividend-Sales Q/Q-4.94%
Insider Own18.87%Inst Own56.86%
Insider Trans4.24%Inst Trans4.65%
Short Float4.08%EarningsMay 06/b
Analyst Recom1.43Target Price10.00
Avg Volume805.07K52W Range0.36 - 6.04
Jul-11-24 03:24PM 7 Growth Stocks to Buy for Under $5 for Massive Gains (InvestorPlace) +20.32%
Jul-08-24 02:00AM Myricx Bio Announces 90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development (GlobeNewswire) -6.13%
Jul-01-24 04:05PM ADC Therapeutics Makes Grants to New Employees Under Inducement Plan (GlobeNewswire) +16.46% -5.43%
Jun-27-24 07:15AM ADC Therapeutics Set to Join Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
Jun-13-24 02:31PM Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget (InvestorPlace)
Jun-03-24 04:05PM ADC Therapeutics Makes Grants to New Employees Under Inducement Plan (GlobeNewswire) +5.74%
May-30-24 07:15AM ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-24 07:15AM ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ (GlobeNewswire)
May-09-24 07:01PM Insider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT) (GuruFocus.com) -5.91%
07:15AM ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
FBLG - FibroBiologics Inc - Stock Price Chart
TickerFBLG [NASD, RUT]
CompanyFibroBiologics Inc
CountryUSA
IndustryBiotechnology
Market Cap183.24MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-437.63%
Dividend-Sales Q/Q-
Insider Own25.36%Inst Own2.27%
Insider Trans0.00%Inst Trans-
Short Float2.43%EarningsMay 29
Analyst Recom-Target Price-
Avg Volume244.74K52W Range3.90 - 55.00
Jul-15-24 09:31AM FibroBiologics to Present at JonesTrading Healthcare Summit 2024 (GlobeNewswire) +5.49%
Jun-25-24 09:31AM FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology (GlobeNewswire)
Jun-13-24 09:31AM FibroBiologics Set to Join Russell 2000 Index (GlobeNewswire) -6.14%
Jun-06-24 09:31AM FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024 (GlobeNewswire) +53.88%
May-15-24 04:30PM FibroBiologics Announces 2024 Annual Meeting of Stockholders (GlobeNewswire)
09:54AM FBLG Stock Earnings: FibroBiologics, Inc. - Common Stock Reported Results for Q1 2024 (InvestorPlace)
May-14-24 05:24PM FibroBiologics Files 2024 First Quarter Report (GlobeNewswire) +10.35%
May-07-24 09:31AM FibroBiologics to Present at the BIO International Convention 2024 (GlobeNewswire) +5.49%
Apr-25-24 08:00AM FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids (GlobeNewswire)
Apr-11-24 09:31AM FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office (GlobeNewswire)
IINN - Inspira Technologies Oxy B.H.N. Ltd - Stock Price Chart
TickerIINN [NASD]
CompanyInspira Technologies Oxy B.H.N. Ltd
CountryIsrael
IndustryMedical Devices
Market Cap20.01MEPS (ttm)-0.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-28.83%
P/S-EPS next 5Y-
P/B2.97EPS Q/Q95.19%
Dividend-Sales Q/Q-
Insider Own8.92%Inst Own0.51%
Insider Trans0.00%Inst Trans43.45%
Short Float0.23%Earnings-
Analyst Recom1.00Target Price13.00
Avg Volume154.18K52W Range0.76 - 2.49
Jul-11-24 08:30AM Inspira Receives Israeli Regulatory Approval for the INSPIRA ART100 System (PR Newswire)
Jun-21-24 11:12AM Inspira (IINN) Unveils Business Targets for 2024-25 (Zacks)
Jun-20-24 09:25AM Inspira Announces Business Plan Targets (PR Newswire) -14.11%
Jun-17-24 08:30AM Inspira Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel (PR Newswire) -7.89%
08:30AM Inspira Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECMOs Conference in Israel (PR Newswire)
Jun-13-24 08:30AM Inspira Receives First Ever Purchase Order for INSPIRA ART100 Systems in the U.S. (PR Newswire)
Jun-05-24 08:30AM Inspira to Exhibit the FDA Cleared INSPIRA ART100 System at a World-Renowned Event in the Sector (PR Newswire)
May-30-24 08:30AM Inspira Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments (PR Newswire) +5.45%
May-29-24 12:13PM Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant (Zacks) +10.00%
May-28-24 09:25AM INSPIRA ART100 Receives FDA 510(k) Clearance (PR Newswire) -8.68%
PRCH - Porch Group Inc - Stock Price Chart
TickerPRCH [NASD, RUT]
CompanyPorch Group Inc
CountryUSA
IndustrySoftware - Application
Market Cap209.29MEPS (ttm)-1.13
P/E-EPS this Y58.20%
Forward P/E-EPS next Y-6.53%
PEG-EPS past 5Y-
P/S0.46EPS next 5Y-
P/B-EPS Q/Q66.33%
Dividend-Sales Q/Q32.13%
Insider Own23.52%Inst Own52.79%
Insider Trans-0.38%Inst Trans-13.70%
Short Float12.52%EarningsAug 06/a
Analyst Recom1.75Target Price5.46
Avg Volume1.23M52W Range0.50 - 4.78
Jul-25-24 08:30AM Porch Group to Release Second Quarter 2024 Earnings on August 6, 2024 (Business Wire)
Jul-04-24 12:31PM 7 Overlooked Penny Stocks That Could Quintuple Your Money by 2026 (InvestorPlace)
May-10-24 09:00AM Porch Group Announces Attendance At Upcoming Investor Events (Business Wire) -8.26%
May-09-24 12:00PM Porch Group, Inc. (NASDAQ:PRCH) Q1 2024 Earnings Call Transcript (Insider Monkey) +6.27%
May-08-24 09:58PM PRCH Stock Earnings: Porch Group Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:30PM Porch Group, Inc. (PRCH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:02PM Porch Group Reports First Quarter 2024 Results (Business Wire)
Apr-24-24 05:07PM Porch Group to Release First Quarter 2024 Earnings on May 8, 2024 (Business Wire)
Apr-09-24 04:01PM Porch Group Announces Inspection Product Enhancements and Price Increases (Business Wire)
Mar-14-24 04:02PM Porch Group Attendance At Various Upcoming Investor Events (Business Wire) -6.22% -7.96%
GNLX - Genelux Corp - Stock Price Chart
TickerGNLX [NASD]
CompanyGenelux Corp
CountryUSA
IndustryBiotechnology
Market Cap75.23MEPS (ttm)-0.97
P/E-EPS this Y23.92%
Forward P/E-EPS next Y-28.42%
PEG-EPS past 5Y-23.84%
P/S7522.65EPS next 5Y-
P/B3.92EPS Q/Q30.73%
Dividend-Sales Q/Q-95.29%
Insider Own20.78%Inst Own17.76%
Insider Trans-3.37%Inst Trans-
Short Float4.95%EarningsMay 09/a
Analyst Recom1.00Target Price23.50
Avg Volume289.67K52W Range1.71 - 30.44
May-24-24 08:00AM Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants (GlobeNewswire) -43.04%
May-23-24 04:01PM Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire) -5.35%
May-09-24 11:53PM GNLX Stock Earnings: Genelux Misses EPS for Q1 2024 (InvestorPlace) +6.07%
04:25PM Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates (GlobeNewswire)
Apr-26-24 09:35AM Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-23-24 09:35AM Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-05-24 09:35AM After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX) (Zacks)
Apr-04-24 12:00PM All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy (Zacks)
Apr-02-24 07:52AM GNLX Stock Earnings: Genelux Misses EPS for Q4 2023 (InvestorPlace)
Apr-01-24 07:00AM Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire) -18.51%
OPRX - OptimizeRx Corp - Stock Price Chart
TickerOPRX [NASD, RUT]
CompanyOptimizeRx Corp
CountryUSA
IndustryHealth Information Services
Market Cap195.49MEPS (ttm)-1.02
P/E-EPS this Y15.70%
Forward P/E21.12EPS next Y68.43%
PEG-EPS past 5Y-
P/S2.50EPS next 5Y11.50%
P/B1.59EPS Q/Q-1.44%
Dividend-Sales Q/Q51.43%
Insider Own13.33%Inst Own70.51%
Insider Trans0.00%Inst Trans-10.20%
Short Float6.35%EarningsAug 08/a
Analyst Recom1.25Target Price16.64
Avg Volume133.80K52W Range6.92 - 16.65
Jul-25-24 07:30AM OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET (GlobeNewswire)
Jul-23-24 07:30AM OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation (GlobeNewswire)
Jul-15-24 07:30AM OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients (GlobeNewswire)
Jun-20-24 07:30AM New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations (GlobeNewswire)
May-14-24 08:56PM OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +25.67%
04:01PM OptimizeRx Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-13-24 09:55AM Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect? (Zacks)
May-06-24 04:30PM OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-26-24 07:30AM OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET (GlobeNewswire) +15.00%
Apr-23-24 09:35AM After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX) (Zacks)
IVA - Inventiva ADR - Stock Price Chart
TickerIVA [NASD]
CompanyInventiva ADR
CountryFrance
IndustryBiotechnology
Market Cap119.40MEPS (ttm)-2.63
P/E-EPS this Y24.69%
Forward P/E-EPS next Y34.42%
PEG-EPS past 5Y-6.40%
P/S6.32EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own10.62%Inst Own6.47%
Insider Trans0.00%Inst Trans-
Short Float0.30%EarningsMay 21/b
Analyst Recom1.00Target Price19.00
Avg Volume12.84K52W Range2.15 - 4.75
Jul-25-24 04:00PM Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor (GlobeNewswire)
Jul-19-24 11:30AM Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux (GlobeNewswire)
Jul-18-24 02:30AM Inventiva announces a 20.1 million issuance of royalty certificates (GlobeNewswire)
Jul-05-24 04:00PM Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position (GlobeNewswire) -10.85%
Jun-21-24 04:05PM Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024 (GlobeNewswire) -8.25%
04:00PM Results of the votes of the Combined Shareholders' General Meeting of June 20, 2024 (GlobeNewswire)
Jun-18-24 09:35AM Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA) (Zacks)
May-30-24 02:30AM Statement of total voting rights and shares forming the companys share capital as of May 13, 2024 (GlobeNewswire)
02:30AM Combined General Meeting of June 20, 2024 - Availability of the preparatory documents (GlobeNewswire)
May-22-24 04:00PM Inventiva announces two scientific presentations at the EASL International Liver Congress 2024 (GlobeNewswire)
1⋯10⋯151617181920
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.